相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified:: report from the International Peripheral T-Cell Lymphoma Project
Kerry J. Savage et al.
BLOOD (2008)
Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas
Itziar Salaverria et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Enabling personalized cancer medicine through analysis of gene-expression patterns
Laura J. van 't Veer et al.
NATURE (2008)
Translating insights from the cancer genome into clinical practice
Lynda Chin et al.
NATURE (2008)
The anaplastic lymphoma kinase in the pathogenesis of cancer
Roberto Chiarle et al.
NATURE REVIEWS CANCER (2008)
Gene expression analysis of Angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation
Pier Paolo Piccaluga et al.
CANCER RESEARCH (2007)
Identification and validation of biomarkers of IgVH mutation status in chronic lymphocytic leukemia using microfluiclics quantitative real-time polymerase chain reaction technology
Lynne V. Abruzzo et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets
Pier Paolo Piccaluga et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes
Laurence Lamant et al.
BLOOD (2007)
FLAME, a novel fuzzy clustering method for the analysis of DNA microarray data
Limin Fu et al.
BMC BIOINFORMATICS (2007)
Functional validation of the analplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes
Roberto Piva et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein β in ALK-positive anaplastic large cell lymphoma
Leticia Quintanilla-Martinez et al.
BLOOD (2006)
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen
J Moffat et al.
CELL (2006)
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
R Piva et al.
BLOOD (2006)
Lymphorna incidence patterns by WHO subtype in the United States, 1992-2001
LM Morton et al.
BLOOD (2006)
A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein β and NF-κB activity in Hodgkin and anaplastic large cell lymphomas
F Jundt et al.
BLOOD (2005)
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
R Chiarle et al.
NATURE MEDICINE (2005)
Differential gene expression in anaptastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas
MA Thompson et al.
HUMAN PATHOLOGY (2005)
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma
M Mattioli et al.
ONCOGENE (2005)
Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells
M Chatterjee et al.
BLOOD (2004)
Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling
I Bonzheim et al.
BLOOD (2004)
Oncogenomics and the development of new cancer therapies
RL Strausberg et al.
NATURE (2004)
Gene expression profiling in anaplastic large cell lymphoma and Hodgkin's disease
P Trempat et al.
LEUKEMIA & LYMPHOMA (2004)
Conditional suppression of cellular genes: Lentivirus vector-mediated drug-inducible RNA interference
M Wiznerowicz et al.
JOURNAL OF VIROLOGY (2003)
ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects - a review
RL ten Berge et al.
JOURNAL OF PATHOLOGY (2003)
ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified
RL ten Berge et al.
HISTOPATHOLOGY (2003)
Diagnosis of multiple cancer types by shrunken centroids of gene expression
R Tibshirani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
A Zamo et al.
ONCOGENE (2002)
Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells
U Klein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)